Aude Mallavialle

5PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 21, 2025
Cathepsins: Novel opportunities for antibody therapeutics in cancer.

Timothée David, Pénélope Desroys du Roure, Aude Mallavialle

|Feb 06, 2023
The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential.

Kenji F Shoji, Elsa Bayet, Sabrina Leverrier-Penna

|Nov 08, 2022
SPARC in cancer-associated fibroblasts is an independent poor prognostic factor in non-metastatic triple-negative breast cancer and exhibits pro-tumor activity.

Lindsay B Alcaraz, Aude Mallavialle, Caroline Mollevi

|May 03, 2022
Secretion of IL1 by Dedifferentiated Melanoma Cells Inhibits JAK1-STAT3-Driven Actomyosin Contractility of Lymph Node Fibroblastic Reticular Cells.

Christopher Rovera, Ilona Berestjuk, Margaux Lecacheur

|May 21, 2020
Co-Expression of Androgen Receptor and Cathepsin D Defines a Triple-Negative Breast Cancer Subgroup with Poorer Overall Survival.

Hanane Mansouri, Lindsay B Alcaraz, Caroline Mollevi

Pageof 1

Frequent Collaborators

2 joint publications

Lindsay B Alcaraz

2 joint publications

William Jacot

2 joint publications

Séverine Guiu

2 joint publications

Pascal Roger